Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

BACKGROUND: This study aimed to assess the characteristics of breakthrough cancer pain (BTcP) in patients receiving low doses of opioids for background pain in comparison with patients receiving at least 60 mg of oral morphine equivalents (OME). MATERIALS AND METHODS: Patients with advanced cancer r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Mercadante, Sebastiano, Caraceni, Augusto, Masedu, Francesco, Scipioni, Teresa, Aielli, Federica
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2019
Teme:
Symptom Management and Supportive Care
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011660/
https://ncbi.nlm.nih.gov/pubmed/31862860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0542
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items